Xeltis
PrivateLast Round
Early Funding
Jul 28, 2026
Total Funding Raised
$223.02M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Xeltis is a medical device company that develops bioabsorbable heart valves and blood vessels aimed at promoting natural tissue restoration in cardiovascular therapy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xeltis Comparables
Compare Xeltis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PECA Labs, Inc. | 85% | |
| CorMatrix Cardiovascular, Inc. | 81% | |
| VeriGraft | 81% | |
Xeltis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 28, 2026 | ||||
| VC Round | Dec 2, 2025 | ||||
| Debt | Dec 2, 2025 | ||||
| Corporate Funding | Apr 8, 2025 | ||||
| Series D Extension | Aug 15, 2023 | ||||
Series D | Feb 21, 2023 |
Xeltis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series D Extension, VC Round, Corporate Funding |
| EQT Life Sciences | Series C, Early Funding, Series D Extension, VC Round, Series D, Series B Extension, Series B |
| Invest-NL | Early Funding, Series D Extension, VC Round, Series D |
| Ysios Capital | Series C, Series D |
| Horizon 3 Healthcare | Early Funding |
| VI Partners | Series C, Early Funding, Series D, Series B Extension, Series B |
| European Investment Bank Group | Debt, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
CMO interviewed at LSX World Congress in Lisbon.
- Dec 2, 2025
$58.1M raised in a VC round.
Xeltis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xeltis's valuation, stock price, and market status.